Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000493809 | SCV000583112 | uncertain significance | not provided | 2017-05-25 | criteria provided, single submitter | clinical testing | The S3073G variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. The S3073G variant is observed in 18/66368 (0.03%) alleles from individuals of European background (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). This variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. However, this substitution occurs at a position that is not conserved, and in silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. |
Illumina Laboratory Services, |
RCV001142819 | SCV001303303 | benign | Collagen 6-related myopathy | 2018-01-12 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Labcorp Genetics |
RCV002063859 | SCV002373151 | likely benign | Bethlem myopathy 1A | 2023-07-25 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV000493809 | SCV004235458 | uncertain significance | not provided | 2023-05-24 | criteria provided, single submitter | clinical testing |